Select Page

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. The global Age Related Macular Degeneration Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Age Related Macular Degeneration Treatment market based on company, product type, end user and key regions. This report studies the global market size of Age Related Macular Degeneration Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Age Related Macular Degeneration Treatment in these regions. This research report categorizes the global Age Related Macular Degeneration Treatment market by top players/brands, region, type and end user. This report also studies the global Age Related Macular Degeneration Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Regeneron Pharmaceuticals Bayer HealthCare Novartis Roche Kanghong Pharma Market size by Product Lucentis Eylea Avastin Other Market size by End User Hospital Clinic Other Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Age Related Macular Degeneration Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Age Related Macular Degeneration Treatment market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Age Related Macular Degeneration Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Age Related Macular Degeneration Treatment submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Age Related Macular Degeneration Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Age Related Macular Degeneration Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=90927

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Age Related Macular Degeneration Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Product
1.4.2 Lucentis
1.4.3 Eylea
1.4.4 Avastin
1.4.5 Other
1.5 Market by End User
1.5.1 Global Age Related Macular Degeneration Treatment Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Age Related Macular Degeneration Treatment Market Size
2.1.1 Global Age Related Macular Degeneration Treatment Revenue 2014-2025
2.1.2 Global Age Related Macular Degeneration Treatment Sales 2014-2025
2.2 Age Related Macular Degeneration Treatment Growth Rate by Regions
2.2.1 Global Age Related Macular Degeneration Treatment Sales by Regions
2.2.2 Global Age Related Macular Degeneration Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Age Related Macular Degeneration Treatment Sales by Manufacturers
3.1.1 Age Related Macular Degeneration Treatment Sales by Manufacturers
3.1.2 Age Related Macular Degeneration Treatment Sales Market Share by Manufacturers
3.1.3 Global Age Related Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Age Related Macular Degeneration Treatment Revenue by Manufacturers
3.2.1 Age Related Macular Degeneration Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Age Related Macular Degeneration Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Age Related Macular Degeneration Treatment Price by Manufacturers
3.4 Age Related Macular Degeneration Treatment Manufacturing Base Distribution, Product Types
3.4.1 Age Related Macular Degeneration Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Age Related Macular Degeneration Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Age Related Macular Degeneration Treatment Sales by Product
4.2 Global Age Related Macular Degeneration Treatment Revenue by Product
4.3 Age Related Macular Degeneration Treatment Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Age Related Macular Degeneration Treatment Breakdown Data by End User

6 North America
6.1 North America Age Related Macular Degeneration Treatment by Countries
6.1.1 North America Age Related Macular Degeneration Treatment Sales by Countries
6.1.2 North America Age Related Macular Degeneration Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Age Related Macular Degeneration Treatment by Product
6.3 North America Age Related Macular Degeneration Treatment by End User

7 Europe
7.1 Europe Age Related Macular Degeneration Treatment by Countries
7.1.1 Europe Age Related Macular Degeneration Treatment Sales by Countries
7.1.2 Europe Age Related Macular Degeneration Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Age Related Macular Degeneration Treatment by Product
7.3 Europe Age Related Macular Degeneration Treatment by End User

8 Asia Pacific
8.1 Asia Pacific Age Related Macular Degeneration Treatment by Countries
8.1.1 Asia Pacific Age Related Macular Degeneration Treatment Sales by Countries
8.1.2 Asia Pacific Age Related Macular Degeneration Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Age Related Macular Degeneration Treatment by Product
8.3 Asia Pacific Age Related Macular Degeneration Treatment by End User

9 Central & South America
9.1 Central & South America Age Related Macular Degeneration Treatment by Countries
9.1.1 Central & South America Age Related Macular Degeneration Treatment Sales by Countries
9.1.2 Central & South America Age Related Macular Degeneration Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Age Related Macular Degeneration Treatment by Product
9.3 Central & South America Age Related Macular Degeneration Treatment by End User

10 Middle East and Africa
10.1 Middle East and Africa Age Related Macular Degeneration Treatment by Countries
10.1.1 Middle East and Africa Age Related Macular Degeneration Treatment Sales by Countries
10.1.2 Middle East and Africa Age Related Macular Degeneration Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Age Related Macular Degeneration Treatment by Product
10.3 Middle East and Africa Age Related Macular Degeneration Treatment by End User

11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Products Offered
11.1.5 Regeneron Pharmaceuticals Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Details
11.2.2 Company Business Overview
11.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer HealthCare Age Related Macular Degeneration Treatment Products Offered
11.2.5 Bayer HealthCare Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Age Related Macular Degeneration Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Age Related Macular Degeneration Treatment Products Offered
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Age Related Macular Degeneration Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Roche Age Related Macular Degeneration Treatment Products Offered
11.4.5 Roche Recent Development
11.5 Kanghong Pharma
11.5.1 Kanghong Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Kanghong Pharma Age Related Macular Degeneration Treatment Products Offered
11.5.5 Kanghong Pharma Recent Development

12 Future Forecast
12.1 Age Related Macular Degeneration Treatment Market Forecast by Regions
12.1.1 Global Age Related Macular Degeneration Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Age Related Macular Degeneration Treatment Revenue Forecast by Regions 2019-2025
12.2 Age Related Macular Degeneration Treatment Market Forecast by Product
12.2.1 Global Age Related Macular Degeneration Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Age Related Macular Degeneration Treatment Revenue Forecast by Product 2019-2025
12.3 Age Related Macular Degeneration Treatment Market Forecast by End User
12.4 North America Age Related Macular Degeneration Treatment Forecast
12.5 Europe Age Related Macular Degeneration Treatment Forecast
12.6 Asia Pacific Age Related Macular Degeneration Treatment Forecast
12.7 Central & South America Age Related Macular Degeneration Treatment Forecast
12.8 Middle East and Africa Age Related Macular Degeneration Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Age Related Macular Degeneration Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-age-related-macular-degeneration-treatment-market-insights-forecast